A Study of MK0657 in Parkinson's Disease Patients (0657-006)
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
In this clinical trial, the safety of MK0657 when given with levodopa will be assessed in
patients with Parkinson's Disease. This study will also measure the effectiveness of MK0657,
when given in combination with levodopa, to improve motor symptoms and ameliorate dyskinesias
(uncontrolled movements of a part of the body) as compared to placebo.